article thumbnail

Eli Lilly promises additional $1.6b manufacturing investment

European Pharmaceutical Review

billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceutical manufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. Students will also be able to access a smart manufacturing lab.

article thumbnail

Trends in Virtual Collaboration

Impetus Digital

Educational platforms for live and on-demand knowledge-sharing Lastly, the pandemic brought many changes in how healthcare providers and patients want to access content and knowledge-sharing opportunities. Some want to attend live meetings (whether web-based, hybrid, or in person) to be able to network “face-to-face.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

The LSIMF was announced within an overall investment of £354 million for life sciences manufacturing, said MMIP, which added it will be “important to understand how and when the remaining £294 million will be allocated.” ” Image from the Association of the British Pharmaceutical Industry (ABPI). .

article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Criminal networks are penetrating established digital and ecommerce channels, benefitting from their trusted authenticity and authority to distribute fake products to unsuspecting patients.

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

FDI experts at Investment Monitor have highlighted the following list of factors as most important to life sciences companies considering a greenfield investment in 2022: labour, education, industry clusters, domestic market, infrastructure, business environment, costs and quality of life. Labour and education. Industry clusters.

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

Timely delivers the clinical education patients need to be informed about their medication, the financial support to aid affordability, and the personalized behavioral reminders at critical points in the therapeutic journey—from first fill to renewal—to help patients stay on course with their provider’s treatment plan.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

With the myriad of guidance and recommendations to boost diversity and inclusion in oncology trials, , biotech and pharmaceutical manufacturers are left to interpret the criteria and implement them through tangible action. J National Comprehensive Cancer Network. 2019;17(11):1309-1316. doi:10.6004/jnccn.2019.7321